NEW YORK (GenomeWeb News) – Arrayit said today that Sandia National Laboratories will use the company’s nanotechnology platform to develop microarrays for use in anti-bioterror efforts.

Sandia Labs will use Arrayit’s nanoliter technology to develop microarrays, biosensors, and other sensor tools for use in detecting biological and chemical agents that could be part of a terrorism event.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.

The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.

Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.

In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.